Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing, 400715, China.
Shanghai Key Laboratory of Artificial Intelligence for Medical Image and Knowledge Graph, Shanghai, 200336, China.
Adv Healthc Mater. 2021 Jul;10(13):e2100311. doi: 10.1002/adhm.202100311. Epub 2021 May 8.
Membrane camouflaged-nanoparticles (CM-NPs) have been exploited to inherit desired functionalities from source cells. Despite those advantages, membrane cloak may play a "double-edged sword" role in tumor-targeting therapy, as the intact membrane coating may hinder function-exertion of loaded drugs after reaching predetermined site. Therefore, further optimization of CM-NPs is still needed to enhance their delivery efficiency. Herein, natural product, Solamargine (SM), a cholesterol-affiliative amphiphilic potato alkaloid is first applied as core component of "inner core," to design a cell-mimicking "core-shell" nanoparticle (RBC-SLip) with acid-responsive off-coating properties for tumor-targeted therapy. Owing to red blood cell membrane (RBCm)-derived outer coating, it circulates stably in physiological conditions. While it would undergo an off-coating morphological change in response to acid stimuli in tumor microenvironment (TME), afterwards, the resulting off-coating liposome (SLip) shows active tumor-targeting and endosomal escape abilities, thus contributing to superior antitumor efficacy. In addition, SM also possesses natural TME-modulating ability; therefore, RBC-SLip can synergize with the PD1/PD-L1 blockade immunotherapy when encapsulated with PTX to achieve enhanced chemoimmunotherapy. The off-coating strategy developed by natural products SM, provide a brand-new perspective to optimize CM-NPs, and it also embodies application value of "unification of medicines and excipients" of natural products.
细胞膜伪装纳米颗粒 (CM-NPs) 已被用于从源细胞继承所需的功能。尽管有这些优势,但膜伪装在肿瘤靶向治疗中可能扮演“双刃剑”的角色,因为完整的膜涂层可能会阻碍到达预定部位后负载药物的功能发挥。因此,仍然需要进一步优化 CM-NPs,以提高其递送效率。在此,首次将天然产物番茄碱 (SM) 作为“内核”的核心成分,设计一种具有酸响应脱壳性能的细胞模拟“核壳”纳米颗粒 (RBC-SLip),用于肿瘤靶向治疗。由于具有红细胞膜 (RBCm) 衍生的外层涂层,它在生理条件下能够稳定循环。然而,当遇到肿瘤微环境 (TME) 中的酸性刺激时,它会经历脱壳形态变化,随后,所得的脱壳脂质体 (SLip) 显示出主动的肿瘤靶向和内体逃逸能力,从而提高了抗肿瘤疗效。此外,SM 还具有天然的 TME 调节能力;因此,当与 PTX 一起封装时,RBC-SLip 可以与 PD1/PD-L1 阻断免疫疗法协同作用,实现增强的化疗免疫治疗。天然产物 SM 开发的脱壳策略为优化 CM-NPs 提供了全新的视角,也体现了天然产物“药辅合一”的应用价值。